SlideShare une entreprise Scribd logo
1  sur  22
Télécharger pour lire hors ligne
Cinderella is the first Dutch not-for-profit
organization making new drugs available for an
affordable price.
Cinderella focuses on step child drugs:
Promising drugs, but of low interest to the
commercial pharmaceutical industry due to their
low potential to generate profits.
Cinderella is convinced
the clinical development of stepchild drugs can be
completed successfully by the application on novel
study methodology.
To reach this goal
Cinderella renounces the profit principle and adopts
top clinical physician/scientists to execute her
projects. Charity organizations and individuals who
subscribe to Cinderella’s approach will provide the
necessary financial support .
Initiate development of stepchild drugs
by initiating clinical:
Renouncing the profit principle.
Selecting the most promising step child drugs.
Cinderella’s drug selection:
Drugs shelved by the pharmaceutical industry
for their lack of profit making potential.
Drugs promising a high therapeutic ratio based
on results obtained in preclinical research and
phase 1 studies.
Cinderella is only interested in phase 2 studies:
Phase 2 studies can be completed
in a brief period of time at low costs
Short study duration and low costs are achieved by
entering limited numbers of patients on study
(approx. 30).
Drugs shelved for their inability to generate a
sizeable profit can still be studied in patients.
Advantages of Cinderella’s approach:
Drugs shelved for their inability to generate a
sizeable profit can still be studied in patients.
All studies focused on improving the quality of life
of the patient. Top medical specialists are the
principal investigators.
Advantages of Cinderella’s approach:
Drugs shelved for their inability to generate a
sizeable profit can still be studied in patients.
All studies focused on improving the quality of life
of the patient. Top medical specialists are the
principal investigators.
Coordination is in the hands of the Cinderella
Therapeutics Research Corporation.
Advantages of Cinderella’s approach:
Drugs shelved for their inability to generate a
sizeable profit can still be studied in patients.
All studies focused on improving the quality of life
of the patient. Top medical specialists are the
principal investigators.
Coordination is in the hands of the Cinderella
Therapeutics Research Corporation.
A corporate approach leads to higher efficiency.
Advantages of Cinderella’s approach:
Advantages of Cinderella’s approach:
Cinderella subscribes to
the open source principle.
Cinderella subscribes to
the open source principle.
Obtained results will be published forthwith
in scientific journals.
Advantages of Cinderella’s approach:
Cinderella subscribes to
the open source principle.
Obtained results will be published forthwith
in scientific journals.
Patent applications to protect commercial
interests have become obsolete.
Advantages of Cinderella’s approach:
No marketing costs.
Advantages of Cinderella’s approach:
No marketing costs.
Therapies found to be ineffective in Cinderella
studies will not increase the price charged
for other, new and effective Cinderella therapies.
Advantages of Cinderella’s approach:
No marketing costs.
Therapies found to be ineffective in Cinderella
studies will not increase the price charged
for other, new and effective Cinderella therapies.
Cinderella’s new type of drug development will be
10 to 100 times cheaper than the current drug
development strategy of the Pharmaceutical
Industry.
Advantages of Cinderella’s approach:
Cinderella's approach

Contenu connexe

Tendances (7)

Teresa Sardon / System biology approaches to personalized medicine
Teresa Sardon / System biology approaches to personalized medicineTeresa Sardon / System biology approaches to personalized medicine
Teresa Sardon / System biology approaches to personalized medicine
 
samba resume pdf
samba  resume pdfsamba  resume pdf
samba resume pdf
 
Enhancing business performance through research
Enhancing business performance through researchEnhancing business performance through research
Enhancing business performance through research
 
Navigating Patients to Clinical Trials
Navigating Patients to Clinical TrialsNavigating Patients to Clinical Trials
Navigating Patients to Clinical Trials
 
Evidence based medicine
Evidence based medicineEvidence based medicine
Evidence based medicine
 
My thesis
My thesisMy thesis
My thesis
 
Presentation
PresentationPresentation
Presentation
 

Similaire à Cinderella's approach

Aiden hollis hif presentation berkeley
Aiden hollis   hif presentation berkeleyAiden hollis   hif presentation berkeley
Aiden hollis hif presentation berkeley
Open Science Summit
 
Challenges for drug development jsr slides aug 2013
Challenges for drug development jsr slides aug 2013Challenges for drug development jsr slides aug 2013
Challenges for drug development jsr slides aug 2013
CincyTechUSA
 
Clinical Trials Introduction
Clinical Trials IntroductionClinical Trials Introduction
Clinical Trials Introduction
biinoida
 
Herantis Pharma - A new pharmaceutical company
Herantis Pharma - A new pharmaceutical companyHerantis Pharma - A new pharmaceutical company
Herantis Pharma - A new pharmaceutical company
herantis
 

Similaire à Cinderella's approach (20)

Aiden hollis hif presentation berkeley
Aiden hollis   hif presentation berkeleyAiden hollis   hif presentation berkeley
Aiden hollis hif presentation berkeley
 
The Role of clinical Research in Pharmaceuticals Industry
The Role of clinical Research in Pharmaceuticals IndustryThe Role of clinical Research in Pharmaceuticals Industry
The Role of clinical Research in Pharmaceuticals Industry
 
Clinical research course
Clinical research courseClinical research course
Clinical research course
 
Clinical trials ppt. Dr. Zubair Ali
Clinical trials ppt. Dr. Zubair AliClinical trials ppt. Dr. Zubair Ali
Clinical trials ppt. Dr. Zubair Ali
 
Canada’s Orphan Drug Regulatory Framework & panCanadian Access to Rare Diseas...
Canada’s Orphan Drug Regulatory Framework & panCanadian Access to Rare Diseas...Canada’s Orphan Drug Regulatory Framework & panCanadian Access to Rare Diseas...
Canada’s Orphan Drug Regulatory Framework & panCanadian Access to Rare Diseas...
 
Ana Mingorance crdn summit 2017
Ana Mingorance crdn summit 2017Ana Mingorance crdn summit 2017
Ana Mingorance crdn summit 2017
 
Drugtesting
DrugtestingDrugtesting
Drugtesting
 
Clinical Aspect of Drug Discovery and Development PCO 413.pptx
Clinical Aspect of Drug Discovery and Development PCO 413.pptxClinical Aspect of Drug Discovery and Development PCO 413.pptx
Clinical Aspect of Drug Discovery and Development PCO 413.pptx
 
Pulmorphix Slidedeck
Pulmorphix SlidedeckPulmorphix Slidedeck
Pulmorphix Slidedeck
 
Challenges for drug development jsr slides aug 2013
Challenges for drug development jsr slides aug 2013Challenges for drug development jsr slides aug 2013
Challenges for drug development jsr slides aug 2013
 
Views for collaboration between pharmaceutical industry and academia a haapal...
Views for collaboration between pharmaceutical industry and academia a haapal...Views for collaboration between pharmaceutical industry and academia a haapal...
Views for collaboration between pharmaceutical industry and academia a haapal...
 
Clinical Trials Introduction
Clinical Trials IntroductionClinical Trials Introduction
Clinical Trials Introduction
 
Il processo di innovazione in atto: dalle strategie di brevettazione al fundr...
Il processo di innovazione in atto: dalle strategie di brevettazione al fundr...Il processo di innovazione in atto: dalle strategie di brevettazione al fundr...
Il processo di innovazione in atto: dalle strategie di brevettazione al fundr...
 
IND Enabling Studies by Kashikant Yadav
IND Enabling Studies by Kashikant YadavIND Enabling Studies by Kashikant Yadav
IND Enabling Studies by Kashikant Yadav
 
durgesh final
durgesh finaldurgesh final
durgesh final
 
Launching a new product.pptx
Launching a new product.pptxLaunching a new product.pptx
Launching a new product.pptx
 
Herantis Pharma - A new pharmaceutical company
Herantis Pharma - A new pharmaceutical companyHerantis Pharma - A new pharmaceutical company
Herantis Pharma - A new pharmaceutical company
 
Discovery of Drug and Introduction to Clinical Trial_Katalyst HLS
Discovery of Drug and Introduction to Clinical Trial_Katalyst HLSDiscovery of Drug and Introduction to Clinical Trial_Katalyst HLS
Discovery of Drug and Introduction to Clinical Trial_Katalyst HLS
 
Clinical Trials on Repurposed Treatments for Immediate Incorporation into Cli...
Clinical Trials on Repurposed Treatments for Immediate Incorporation into Cli...Clinical Trials on Repurposed Treatments for Immediate Incorporation into Cli...
Clinical Trials on Repurposed Treatments for Immediate Incorporation into Cli...
 
Basics of Drug Discovery and Development
Basics of Drug Discovery and DevelopmentBasics of Drug Discovery and Development
Basics of Drug Discovery and Development
 

Dernier

ابو ظبي اعلان | - سايتوتك في الامارات حبوب الاجهاض للبيع ف حبوب الإجهاض ... ا...
ابو ظبي اعلان | - سايتوتك في الامارات حبوب الاجهاض للبيع ف حبوب الإجهاض ... ا...ابو ظبي اعلان | - سايتوتك في الامارات حبوب الاجهاض للبيع ف حبوب الإجهاض ... ا...
ابو ظبي اعلان | - سايتوتك في الامارات حبوب الاجهاض للبيع ف حبوب الإجهاض ... ا...
brennadilys816
 
Apotik Jual Obat Aborsi asli Mataram, Wa : 085180626899 - Penjual obat Cytote...
Apotik Jual Obat Aborsi asli Mataram, Wa : 085180626899 - Penjual obat Cytote...Apotik Jual Obat Aborsi asli Mataram, Wa : 085180626899 - Penjual obat Cytote...
Apotik Jual Obat Aborsi asli Mataram, Wa : 085180626899 - Penjual obat Cytote...
jual Obat Aborsi Bandung, Wa : 085180626899 Apotik jual Obat Cytotec Di Bandung
 

Dernier (20)

Daftar Rumpun, Pohon, dan Cabang Ilmu (2024).pdf
Daftar Rumpun, Pohon, dan Cabang Ilmu (2024).pdfDaftar Rumpun, Pohon, dan Cabang Ilmu (2024).pdf
Daftar Rumpun, Pohon, dan Cabang Ilmu (2024).pdf
 
The Truth About Dinesh Bafna's Situation.pdf
The Truth About Dinesh Bafna's Situation.pdfThe Truth About Dinesh Bafna's Situation.pdf
The Truth About Dinesh Bafna's Situation.pdf
 
Raising Seed Capital by Steve Schlafman at RRE Ventures
Raising Seed Capital by Steve Schlafman at RRE VenturesRaising Seed Capital by Steve Schlafman at RRE Ventures
Raising Seed Capital by Steve Schlafman at RRE Ventures
 
How Do Venture Capitalists Make Decisions?
How Do Venture Capitalists Make Decisions?How Do Venture Capitalists Make Decisions?
How Do Venture Capitalists Make Decisions?
 
ابو ظبي اعلان | - سايتوتك في الامارات حبوب الاجهاض للبيع ف حبوب الإجهاض ... ا...
ابو ظبي اعلان | - سايتوتك في الامارات حبوب الاجهاض للبيع ف حبوب الإجهاض ... ا...ابو ظبي اعلان | - سايتوتك في الامارات حبوب الاجهاض للبيع ف حبوب الإجهاض ... ا...
ابو ظبي اعلان | - سايتوتك في الامارات حبوب الاجهاض للبيع ف حبوب الإجهاض ... ا...
 
Pay after result spell caster (,$+27834335081)@ bring back lost lover same da...
Pay after result spell caster (,$+27834335081)@ bring back lost lover same da...Pay after result spell caster (,$+27834335081)@ bring back lost lover same da...
Pay after result spell caster (,$+27834335081)@ bring back lost lover same da...
 
stock price prediction using machine learning
stock price prediction using machine learningstock price prediction using machine learning
stock price prediction using machine learning
 
MichaelStarkes_UncutGemsProjectSummary.pdf
MichaelStarkes_UncutGemsProjectSummary.pdfMichaelStarkes_UncutGemsProjectSummary.pdf
MichaelStarkes_UncutGemsProjectSummary.pdf
 
Your Work Matters to God RestorationChurch.pptx
Your Work Matters to God RestorationChurch.pptxYour Work Matters to God RestorationChurch.pptx
Your Work Matters to God RestorationChurch.pptx
 
hyundai capital 2023 consolidated financial statements
hyundai capital 2023 consolidated financial statementshyundai capital 2023 consolidated financial statements
hyundai capital 2023 consolidated financial statements
 
Stages of Startup Funding - An Explainer
Stages of Startup Funding - An ExplainerStages of Startup Funding - An Explainer
Stages of Startup Funding - An Explainer
 
Apotik Jual Obat Aborsi asli Mataram, Wa : 085180626899 - Penjual obat Cytote...
Apotik Jual Obat Aborsi asli Mataram, Wa : 085180626899 - Penjual obat Cytote...Apotik Jual Obat Aborsi asli Mataram, Wa : 085180626899 - Penjual obat Cytote...
Apotik Jual Obat Aborsi asli Mataram, Wa : 085180626899 - Penjual obat Cytote...
 
wagamamaLab presentation @MIT 20240509 IRODORI
wagamamaLab presentation @MIT 20240509 IRODORIwagamamaLab presentation @MIT 20240509 IRODORI
wagamamaLab presentation @MIT 20240509 IRODORI
 
Guide to Networking Essentials 8th Edition by Greg Tomsho solution manual.doc
Guide to Networking Essentials 8th Edition by Greg Tomsho solution manual.docGuide to Networking Essentials 8th Edition by Greg Tomsho solution manual.doc
Guide to Networking Essentials 8th Edition by Greg Tomsho solution manual.doc
 
Toyota Kata Coaching for Agile Teams & Transformations
Toyota Kata Coaching for Agile Teams & TransformationsToyota Kata Coaching for Agile Teams & Transformations
Toyota Kata Coaching for Agile Teams & Transformations
 
Innomantra Viewpoint - Building Moonshots : May-Jun 2024.pdf
Innomantra Viewpoint - Building Moonshots : May-Jun 2024.pdfInnomantra Viewpoint - Building Moonshots : May-Jun 2024.pdf
Innomantra Viewpoint - Building Moonshots : May-Jun 2024.pdf
 
WAM Corporate Presentation May 2024_w.pdf
WAM Corporate Presentation May 2024_w.pdfWAM Corporate Presentation May 2024_w.pdf
WAM Corporate Presentation May 2024_w.pdf
 
NFS- Operations Presentation - Recurrent
NFS- Operations Presentation - RecurrentNFS- Operations Presentation - Recurrent
NFS- Operations Presentation - Recurrent
 
Progress Report - UKG Analyst Summit 2024 - A lot to do - Good Progress1-1.pdf
Progress Report - UKG Analyst Summit 2024 - A lot to do - Good Progress1-1.pdfProgress Report - UKG Analyst Summit 2024 - A lot to do - Good Progress1-1.pdf
Progress Report - UKG Analyst Summit 2024 - A lot to do - Good Progress1-1.pdf
 
The Risks of Ignoring Bookkeeping in Your Business
The Risks of Ignoring Bookkeeping in Your BusinessThe Risks of Ignoring Bookkeeping in Your Business
The Risks of Ignoring Bookkeeping in Your Business
 

Cinderella's approach

  • 1.
  • 2.
  • 3. Cinderella is the first Dutch not-for-profit organization making new drugs available for an affordable price.
  • 4. Cinderella focuses on step child drugs: Promising drugs, but of low interest to the commercial pharmaceutical industry due to their low potential to generate profits.
  • 5. Cinderella is convinced the clinical development of stepchild drugs can be completed successfully by the application on novel study methodology.
  • 6. To reach this goal Cinderella renounces the profit principle and adopts top clinical physician/scientists to execute her projects. Charity organizations and individuals who subscribe to Cinderella’s approach will provide the necessary financial support .
  • 7.
  • 8. Initiate development of stepchild drugs by initiating clinical: Renouncing the profit principle. Selecting the most promising step child drugs.
  • 9. Cinderella’s drug selection: Drugs shelved by the pharmaceutical industry for their lack of profit making potential. Drugs promising a high therapeutic ratio based on results obtained in preclinical research and phase 1 studies.
  • 10. Cinderella is only interested in phase 2 studies: Phase 2 studies can be completed in a brief period of time at low costs Short study duration and low costs are achieved by entering limited numbers of patients on study (approx. 30).
  • 11.
  • 12. Drugs shelved for their inability to generate a sizeable profit can still be studied in patients. Advantages of Cinderella’s approach:
  • 13. Drugs shelved for their inability to generate a sizeable profit can still be studied in patients. All studies focused on improving the quality of life of the patient. Top medical specialists are the principal investigators. Advantages of Cinderella’s approach:
  • 14. Drugs shelved for their inability to generate a sizeable profit can still be studied in patients. All studies focused on improving the quality of life of the patient. Top medical specialists are the principal investigators. Coordination is in the hands of the Cinderella Therapeutics Research Corporation. Advantages of Cinderella’s approach:
  • 15. Drugs shelved for their inability to generate a sizeable profit can still be studied in patients. All studies focused on improving the quality of life of the patient. Top medical specialists are the principal investigators. Coordination is in the hands of the Cinderella Therapeutics Research Corporation. A corporate approach leads to higher efficiency. Advantages of Cinderella’s approach:
  • 16. Advantages of Cinderella’s approach: Cinderella subscribes to the open source principle.
  • 17. Cinderella subscribes to the open source principle. Obtained results will be published forthwith in scientific journals. Advantages of Cinderella’s approach:
  • 18. Cinderella subscribes to the open source principle. Obtained results will be published forthwith in scientific journals. Patent applications to protect commercial interests have become obsolete. Advantages of Cinderella’s approach:
  • 19. No marketing costs. Advantages of Cinderella’s approach:
  • 20. No marketing costs. Therapies found to be ineffective in Cinderella studies will not increase the price charged for other, new and effective Cinderella therapies. Advantages of Cinderella’s approach:
  • 21. No marketing costs. Therapies found to be ineffective in Cinderella studies will not increase the price charged for other, new and effective Cinderella therapies. Cinderella’s new type of drug development will be 10 to 100 times cheaper than the current drug development strategy of the Pharmaceutical Industry. Advantages of Cinderella’s approach: